In September 2025, clinical research was published on weight loss for two oral incretin therapies: an oral version of semaglutide and Orforglipron, also a GLP-1 receptor agonist
Combined with regular movement, strength training, quality sleep and stress management, these foods can help you feel fuller, reduce cravings, support healthy blood sugar and make sustainable weight loss feel much easier
doi: 10.1016/j.jhep.2010.01.003 146 MinH-KKapoorAFuchsMMirshahiFZhouHMaherJet al
Sugar reduction for balanced energy and taste adaptation GLP-1 medications can alter taste preferences, making patients more sensitive to sweetness and decreasing preference for high-fat, non-sweet foods during the weight loss phase
Low concentration (2.5 mg/mL): maximum precision, high volume At 2.5 mg/mL, each unit represents just 0.025 mg